Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Triethylamine | HCID 8471 | — |
| Edukt | 1-Methylhomopiperazine | HCID 228349 | — |
| Edukt | 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole | HCID 10489356 | — |
| Edukt | Ethyl acetate hexane | HCID 21226206 | — |
| Lösungsmittel | Dichloromethane methanol | HCID 21226129 | — |
| Produkt | Emedastine | HCID 3219 | — |
Reaktionsschritte
Combine 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole (22.3 g, 99.4 mmol), 1-methyl[1,4]diazepane (19 mL, 152.8 mmol), and triethylamine (75 mL). Heat to 70° C. After 18 hours, add 1-methyl[1,4]diazepane (10 mL) and continue to heat at reflux. After 96 hours, cool to ambient temperature and partition the reaction mixture between water and ethyl acetate. Separate the layers and extract the organic layer with a saturated aqueous sodium bicarbonate solution and then brine. Dry the organic layer over MgSO4, filter, and evaporate in vacuo to give a residue. Chromatograph the residue on silica gel eluting sequentially with 50% ethyl acetate/hexane and then 10% methanol/dichloromethane to give 1-methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepane: Rf=0.52 (silica gel, dichloromethane/methanol/concentrated aqueous ammonia, 90/10/0.1).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06194406B1 |
|---|
| Quelldatensatz | uspto-grants-2001_02 |
|---|
| ORD ID | ord-9a4d5baae8064d5aac0a7606d59f1d28 |
|---|
| Quellennotiz | uspto-grants-2001_02 |
|---|